Sanofi/$SNY
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Ticker
$SNY
Sector
Health
Primary listing
Employees
82,878
Headquarters
Website
Sanofi Metrics
BasicAdvanced
$116B
5.59
$8.60
0.41
$1.60
3.33%
Price and volume
Market cap
$116B
Beta
0.41
52-week high
$60.12
52-week low
$44.73
Average daily volume
2.4M
Dividend rate
$1.60
Financial strength
Current ratio
1.274
Quick ratio
0.811
Long term debt to equity
20.951
Total debt to equity
31.709
Dividend payout ratio (TTM)
52.29%
Interest coverage (TTM)
16.85%
Profitability
EBITDA (TTM)
14,116.609
Gross margin (TTM)
71.32%
Net profit margin (TTM)
19.95%
Operating margin (TTM)
20.51%
Effective tax rate (TTM)
19.24%
Revenue per employee (TTM)
$642,620
Management effectiveness
Return on assets (TTM)
4.65%
Return on equity (TTM)
9.00%
Valuation
Price to earnings (TTM)
5.585
Price to revenue (TTM)
1.114
Price to book
1.42
Price to tangible book (TTM)
5.73
Price to free cash flow (TTM)
6.066
Free cash flow yield (TTM)
16.49%
Free cash flow per share (TTM)
7.921
Dividend yield (TTM)
3.33%
Forward dividend yield
3.33%
Growth
Revenue change (TTM)
15.65%
Earnings per share change (TTM)
117.96%
3-year revenue growth (CAGR)
2.85%
10-year revenue growth (CAGR)
3.35%
3-year earnings per share growth (CAGR)
11.55%
10-year earnings per share growth (CAGR)
7.20%
3-year dividend per share growth (CAGR)
5.59%
10-year dividend per share growth (CAGR)
3.24%
What the Analysts think about Sanofi
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Revenues and expenses
Sanofi Earnings Performance
Company profitability
Sanofi News
AllArticlesVideos
Sanofi stops supply of high cholesterol drug to China due to limited availability
Reuters·1 day ago
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges
WSJ·2 weeks ago
Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days
CNBC Television·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanofi stock?
Sanofi (SNY) has a market cap of $116B as of August 13, 2025.
What is the P/E ratio for Sanofi stock?
The price to earnings (P/E) ratio for Sanofi (SNY) stock is 5.59 as of August 13, 2025.
Does Sanofi stock pay dividends?
Yes, the Sanofi (SNY) stock pays dividends to shareholders. As of August 13, 2025, the dividend rate is $1.59864 and the yield is 3.33%. Sanofi has a payout ratio of 52.29% on a trailing twelve-month basis.
When is the next Sanofi dividend payment date?
The next Sanofi (SNY) dividend payment date is unconfirmed.
What is the beta indicator for Sanofi?
Sanofi (SNY) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.